(EG) Everest - Overview
Stock: Reinsurance, Insurance, Property, Casualty, Specialty
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.36% |
| Yield on Cost 5y | 3.96% |
| Yield CAGR 5y | 6.58% |
| Payout Consistency | 98.9% |
| Payout Ratio | 18.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.3% |
| Relative Tail Risk | -0.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.03 |
| Alpha | -10.59 |
| Character TTM | |
|---|---|
| Beta | 0.471 |
| Beta Downside | 0.585 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.39% |
| CAGR/Max DD | -0.12 |
Description: EG Everest January 02, 2026
Everest Group Ltd (NYSE:EG) is a Bermuda-based insurer and reinsurer that serves the U.S., Europe and global markets through two segments: Insurance and Reinsurance. The firm underwrites a broad suite of property-and-casualty (P&C) products-including mortgage, catastrophe, marine, aviation, engineering, credit & surety, motor, agriculture, and political-violence risks-both directly with ceding companies and via broker networks. It also distributes commercial P&C insurance through wholesale, retail and surplus-lines channels. The company, originally founded in 1973 as Everest Re Group, rebranded to Everest Group in July 2023.
Key operational metrics (2023): net written premiums of approximately $13.5 billion, a combined ratio of 95.5 % indicating underwriting profitability, and a return on equity (ROE) near 13 %. The business is sensitive to two primary sector drivers: (1) the frequency and severity of natural catastrophes, which affect loss reserves and pricing, and (2) the level of interest rates, which influence investment income that historically accounts for roughly 30 % of total earnings.
For a deeper, data-driven view of EG’s valuation dynamics and how its exposure to climate risk and interest-rate environments compares with peers, you may find ValueRay’s analytical tools worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.59b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.25 > 1.0 |
| NWC/Revenue: 52.69% < 20% (prev 63.41%; Δ -10.73% < -1%) |
| CFO/TA 0.05 > 3% & CFO 3.14b > Net Income 1.59b |
| Net Debt (-1.32b) to EBITDA (2.07b): -0.64 < 3 |
| Current Ratio: 10.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.4m) vs 12m ago -3.02% < -2% |
| Gross Margin: 20.52% > 18% (prev 0.14%; Δ 2038 % > 0.5%) |
| Asset Turnover: 29.14% > 50% (prev 30.30%; Δ -1.16% > 0%) |
| Interest Coverage Ratio: 8.19 > 6 (EBITDA TTM 2.07b / Interest Expense TTM 139.0m) |
Altman Z'' 2.32
| A: 0.15 (Total Current Assets 10.04b - Total Current Liabilities 915.0m) / Total Assets 62.51b |
| B: 0.26 (Retained Earnings 16.57b / Total Assets 62.51b) |
| C: 0.02 (EBIT TTM 1.14b / Avg Total Assets 59.43b) |
| D: 0.35 (Book Value of Equity 16.51b / Total Liabilities 47.05b) |
| Altman-Z'' Score: 2.32 = BBB |
What is the price of EG shares?
Over the past week, the price has changed by -0.87%, over one month by -1.18%, over three months by +3.41% and over the past year by -0.02%.
Is EG a buy, sell or hold?
- StrongBuy: 3
- Buy: 3
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 364.9 | 11.1% |
| Analysts Target Price | 364.9 | 11.1% |
| ValueRay Target Price | 331.9 | 1.1% |
EG Fundamental Data Overview February 07, 2026
P/E Forward = 5.6625
P/S = 0.7799
P/B = 0.9053
P/EG = -50.0
Revenue TTM = 17.32b USD
EBIT TTM = 1.14b USD
EBITDA TTM = 2.07b USD
Long Term Debt = 3.59b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 3.59b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.32b USD (from netDebt column, last quarter)
Enterprise Value = 12.96b USD (13.68b + Debt 3.59b - CCE 4.31b)
Interest Coverage Ratio = 8.19 (Ebit TTM 1.14b / Interest Expense TTM 139.0m)
EV/FCF = 3.74x (Enterprise Value 12.96b / FCF TTM 3.47b)
FCF Yield = 26.75% (FCF TTM 3.47b / Enterprise Value 12.96b)
FCF Margin = 20.01% (FCF TTM 3.47b / Revenue TTM 17.32b)
Net Margin = 9.19% (Net Income TTM 1.59b / Revenue TTM 17.32b)
Gross Margin = 20.52% ((Revenue TTM 17.32b - Cost of Revenue TTM 13.76b) / Revenue TTM)
Gross Margin QoQ = 32.87% (prev 12.39%)
Tobins Q-Ratio = 0.21 (Enterprise Value 12.96b / Total Assets 62.51b)
Interest Expense / Debt = 0.70% (Interest Expense 25.0m / Debt 3.59b)
Taxrate = 25.29% (151.0m / 597.0m)
NOPAT = 850.2m (EBIT 1.14b * (1 - 25.29%))
Current Ratio = 10.97 (Total Current Assets 10.04b / Total Current Liabilities 915.0m)
Debt / Equity = 0.23 (Debt 3.59b / totalStockholderEquity, last quarter 15.46b)
Debt / EBITDA = -0.64 (Net Debt -1.32b / EBITDA 2.07b)
Debt / FCF = -0.38 (Net Debt -1.32b / FCF TTM 3.47b)
Total Stockholder Equity = 15.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.68% (Net Income 1.59b / Total Assets 62.51b)
RoE = 10.61% (Net Income TTM 1.59b / Total Stockholder Equity 15.00b)
RoCE = 6.12% (EBIT 1.14b / Capital Employed (Equity 15.00b + L.T.Debt 3.59b))
RoIC = 4.61% (NOPAT 850.2m / Invested Capital 18.43b)
WACC = 6.17% (E(13.68b)/V(17.27b) * Re(7.65%) + D(3.59b)/V(17.27b) * Rd(0.70%) * (1-Tc(0.25)))
Discount Rate = 7.65% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.32%
[DCF Debug] Terminal Value 86.14% ; FCFF base≈4.06b ; Y1≈4.44b ; Y5≈5.63b
Fair Price DCF = 3784 (EV 152.67b - Net Debt -1.32b = Equity 153.99b / Shares 40.7m; r=6.17% [WACC]; 5y FCF grow 10.76% → 2.90% )
EPS Correlation: 3.94 | EPS CAGR: 6.94% | SUE: -0.12 | # QB: 0
Revenue Correlation: 93.47 | Revenue CAGR: 11.95% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-03-31): EPS=14.89 | Chg30d=-0.772 | Revisions Net=-1 | Analysts=11
EPS current Year (2026-12-31): EPS=55.88 | Chg30d=+0.466 | Revisions Net=-3 | Growth EPS=+25.5% | Growth Revenue=-8.1%
EPS next Year (2027-12-31): EPS=62.03 | Chg30d=-0.548 | Revisions Net=-2 | Growth EPS=+11.0% | Growth Revenue=+2.1%